Prescription medication · Non-Selective Beta-Blocker

nadolol

Also sold as Corgard. Nadolol is used to treat angina, which is chest pain.

Data updated 2026-05-15

7,398
FDA reportsLightly reported
3
InteractionsFew interactions
$0.15
Generic price (NADAC)

What the data shows

nadolol (Corgard) is a prescription Non-Selective Beta-Blocker, reported less often than most tracked drugs (7,398 FDA reports), with 3 documented drug interactions.

Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.

nadolol (Corgard) is a prescription Non-Selective Beta-Blocker. Nadolol is used to treat angina, which is chest pain.

Nadolol is a medicine that helps lower blood pressure and manage chest pain (angina). It works by blocking certain natural body chemicals that affect the heart and blood vessels.

Drug Pricing (NADAC)

Generic Price

$0.15/unit

Generic Available

Yes (7 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

NADAC price trail: NADOLOL 20 MG TABLET

Same CMS presentation as the headline generic unit price above (2 effective dates). Adjacent % compares consecutive NADAC releases for this description only, not a patient out-of-pocket quote. Latest step: -2.9% vs prior release.

Effective NADAC / unit vs prior NDCs
February 21, 2024 $0.1525/EA - 1
December 18, 2024 $0.1481/EA -2.9% 13
View Alternatives → Compare with Another Drug → Full Side Effects Report →

What it does

Nadolol is used to treat angina, which is chest pain.

Common side effects

Slow heart rate (less than 60 beats per minute)

Key warnings

If you have heart disease and stop taking nadolol suddenly, it can worsen chest pain or cause a heart attack.

The sections below are summarized in plain English from nadolol's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

Nadolol is a beta-blocker. It works by blocking the effects of certain natural chemicals in your body, such as adrenaline. This helps to slow down your heart rate and relax blood vessels, which lowers blood pressure and reduces chest pain.

Side Effects (from patient reports)

Based on 7,398 FDA adverse event reports.

Most-reported reactions

Adverse reactions in FAERS for nadolol, by number of reports

reports

What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.

Source FDA Adverse Event Reporting System (FAERS) As of 2025

Reports over time

Adverse-event reports filed for nadolol each year to the FDA Adverse Event Reporting System (FAERS).

0200400600800 20042007201020132016201920222025 307

Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.

Where nadolol sits

nadolol has more FDA adverse-event reports than 32% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.

fewest reports most reports

Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is nadolol; the line is the median (50th percentile).

FDA Adverse Event Report Analysis

Detailed analysis of 7,398 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.

Total Reports

7,398

Reports Mentioning Death

602

8.1% of reports — not proof of cause

Hospitalization Reports

2,516

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 4,539 (66%)
Male 2,344 (34%)

Age Distribution

0–17 218
18–44 607
45–64 1,881
65–74 1,277
75+ 714

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
2 MACULAR DEGENERATION 814
3 NAUSEA 663
4 HEADACHE 588
6 FATIGUE 522
7 PAIN 502
8 WEIGHT DECREASED 455
9 DIARRHOEA 433
10 MALAISE 412
11 PYREXIA 397
12 ANAEMIA 342
13 DIZZINESS 333
14 DYSPNOEA 319
15 ABDOMINAL PAIN 317
16 CONSTIPATION 305
17 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 279

Reactions in Death Reports

DEATH 199
COMPLETED SUICIDE 75
TOXICITY TO VARIOUS AGENTS 39
CARDIAC ARREST 32
RENAL FAILURE 31
HEPATIC FAILURE 29
PNEUMONIA 29
DYSPNOEA 28
HYPOTENSION 28
DIARRHOEA 27

Reactions in Hospitalization Reports

NAUSEA 382
PAIN 345
WEIGHT DECREASED 344
PYREXIA 324
MALAISE 314
HEADACHE 307
ANAEMIA 283
ABDOMINAL PAIN 260
THERAPEUTIC PRODUCT EFFECT INCOMPLETE 259
CHRONIC SINUSITIS 252

Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

If you have heart disease and stop taking nadolol suddenly, it can worsen chest pain or cause a heart attack. Your doctor will slowly lower your dose over 1 to 2 weeks. Do not stop taking nadolol without talking to your doctor.

Known Drug Interactions

albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone atenolol metronidazole azithromycin metoprolol caffeine, dietary ingestion nadolol cefaclor nifedipine co-trimoxazole (trimethoprim and sulfamethoxazole) nizatidine diltiazem norfloxacin dirithromycin ofloxacin enflurane omeprazole famotidine prednisone, prednisolone felodipine ranitidine finasteride rifabutin hydrocortisone roxithromycin isoflurane Sorbitol (purgative doses do not inhibit theophylline absorption) isoniazid sucralfate isradipine terbutaline,...

Mechanism: Nadolol is a beta-blocker that can block the airway-opening effects of theophylline, which may make it harder for you to breathe.

Such patients may be unresponsive to the usual doses of epinephrine used to treat allergic reaction.

Mechanism: Nadolol can make your body less responsive to epinephrine, which is the medicine used to treat severe allergic reactions.

Beta Blockers Nadolol a Monitor for adverse reactions.

Mechanism: Itraconazole can slow down how the body breaks down nadolol, which might lead to higher levels of the beta blocker in the blood.

This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.

Common Questions

Can I stop taking nadolol suddenly?
No, you should not stop taking nadolol suddenly, especially if you have heart disease. This can worsen chest pain or cause a heart attack. Your doctor will slowly lower your dose over 1 to 2 weeks.
Can I take nadolol with food?
Yes, you can take nadolol with or without food.
What should I do if I miss a dose?
Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.
How should I store nadolol?
Store nadolol tablets at room temperature (68° to 77°F) and protect them from light.
What are the common side effects of nadolol?
The most common side effect is a slow heart rate (less than 60 beats per minute).
Can nadolol be used during pregnancy?
Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if nadolol will harm your unborn baby.
Can nadolol be used while breastfeeding?
Talk to your doctor about the risks and benefits of taking nadolol while breastfeeding.
What is the usual starting dose of nadolol?
The usual starting dose is 40 mg once a day.
What is nadolol used for?
Nadolol is used to treat angina (chest pain) and high blood pressure.
Does nadolol interact with other medications?
Yes, nadolol can interact with other medications. Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the common side effects of nadolol?
The registry lists Slow heart rate (less than 60 beats per minute) among the most-reported FAERS reaction terms for nadolol. The compiled record contains 7,398 FDA adverse-event reports. These counts are not an individual symptom assessment.
Does nadolol interact with other medications?
The registry has 3 documented interaction rows for nadolol. Notable source-record pairings include theophylline, epinephrine, itraconazole. These rows are not a complete medication review.
What drug class is nadolol?
nadolol belongs to the Non-Selective Beta-Blocker drug class. It requires a prescription (Rx). Nadolol is used to treat angina, which is chest pain.
What pregnancy or breastfeeding source fields are listed for nadolol?
The FDA label for nadolol contains product-specific pregnancy or breastfeeding language. PlainMeds does not apply that source text to an individual.

Other drugs grouped near nadolol - same-class peers and common alternatives.

Compare nadolol vs acebutolol side-by-side →

Compare beyond drug class

Nationwide peers by FAERS volume & death-report share

Two PlainMeds-derived comparison paths for nadolol: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.

Medication Guides

Save on nadolol

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for nadolol

The FDA label for nadolol (sold under brand names such as Corgard) classifies it as a prescription-only medication in the Non-Selective Beta-Blocker class. Nadolol is used to treat angina, which is chest pain. Official labeling lists 1 commonly reported side effect, including Slow heart rate (less than 60 beats per minute).

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 7,398 voluntary reports. The database also lists 3 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS shows a generic unit cost of $0.15.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.

Last updated: May 28, 2024

PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.

All federal data sources used on this page